FDA Brief

Company record

Swisschems

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Swisschems.

Warning letters

  1. Swisschems

    Swisschems sells Semaglutide and Retatrutide as unapproved new drugs despite research-chemical labeling.

    High risk